-
Mashup Score: 14Beyond BCMA: Exploring Talquetamab in Myeloma Therapy - 5 month(s) ago
In this latest episode of ASTCT Talks, Dr. Rahul Banerjee, MD, FACP, sits down with Dr. Amrita Krishnan, MD. They delve into the use of GPRC5D as a target in myeloma therapy, specifically focusing…
Source: nucleus.astct.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6Hypomethylating agent maintenance after allo-HSCT for acute leukemia - 5 month(s) ago
Li L, Zhang R, Cao W, et al. Comparative Analysis of Hypomethylating Agents as Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Acute Leukemia. Leukemia…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
Maintenance therapy with hypomethylating agents may lower the risk of relapse post #alloHSCT and increase survival in patients with high-risk acute leukemia. Read the full article on Nucleus: https://t.co/JQ4coN1G0s #Leusm https://t.co/S4UOuzQy0e
-
-
Mashup Score: 6Spatial transcriptomics biomarker for steroid-resistant aGVHD - 6 month(s) ago
Fang KKL, Lee J, Khatri I, et al. Targeting T-Cell Malignancies Using Allogeneic Double-Negative CD4-CAR-T Cells. Journal for ImmunoTherapy of Cancer. 2023; (doi:…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
Pairing allogeneic double-negative T cells with CAR T cells may represent a viable adoptive cell therapy for r/r T-cell malignancies. Allogeneic DNTs are also good candidates for CAR transduction. Read more on Nucleus: https://t.co/qjBZC62y0J https://t.co/mP5oLoAXKS
-
-
Mashup Score: 12Beyond BCMA: Exploring Talquetamab in Myeloma Therapy - 6 month(s) ago
In this latest episode of ASTCT Talks, Dr. Rahul Banerjee, MD, FACP, sits down with Dr. Amrita Krishnan, MD. They delve into the use of GPRC5D as a target in myeloma therapy, specifically focusing…
Source: nucleus.astct.orgCategories: General Medicine News, Partners & KOLsTweet-
Thanks @DoctorAKrishnan for speaking with me about "Beyond BCMA" in #MMsm for @ASTCT @Emerging_CAR_T Talks! Lots of practical tips from Dr. Krishnan re: managing GPRC5D bsAbs - including some dysgeusia tips borrowed from our transplant colleagues! https://t.co/53PXNY0pFy
-
-
Mashup Score: 1
In this latest episode of ASTCT Talks, Misty Evans, DNP, APRN, CPNP-AC, sits down with Flora Stondell, FNP, to delve into the intricacies of University of California, Davis’ (UC…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
ICYMI: In this episode of ASTCT Talks, @MistyEvansDNP sits down with Flora Stondell, FNP, to delve into @ucdavis transplant and cellular therapy program and their work on #CARTcell therapies. Listen now wherever you access podcasts. https://t.co/7TNkX0jpMT https://t.co/h2PEgIvcUU
-
-
Mashup Score: 4CD24Fc for GVHD prevention in adults undergoing MUD HSCT - 6 month(s) ago
Magenau JM, Jaglowski SM, Uberti J, et al. A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease. Blood. 2023; (doi: 10.1182/blood.2023020250). The results of a new study show that…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
A new study showed patients undergoing human leukocyte antigen-matched unrelated donor #alloHSCT with tacrolimus & methotrexate tolerated CD24Fc well, with high rates of severe acute #GVHD-free survival. Read more on Nucleus: https://t.co/ViZ2fjg2Rz https://t.co/8mkSTwfn31
-
-
Mashup Score: 16
In this latest episode of ASTCT Talks, the October President’s Message, Dr. Andrés Gómez De León is joined by Dr. Miguel Perales, President of ASTCT and Chief of the Adult Bone Marrow…
Source: nucleus.astct.orgCategories: General Medicine News, Onc News and JournalsTweet-
In the latest episode of ASTCT Talks, ASTCT President @DrMiguelPerales and @GomezDLeonMD delve into the vital but often overlooked role of physical activity in #HCT. Listen now on Nucleus, or wherever you get podcasts: https://t.co/fnTBPZw7mB https://t.co/fnqwK9kjlt
-
-
Mashup Score: 0Pre-HCT gut microbiota diversity and outcomes in children - 7 month(s) ago
Masetti R, Leardini D, Muratore E, et al. Gut Microbiota Diversity Before Allogeneic Hematopoietic Stem Cell Transplantation as Predictor of Mortality in Children. Blood. 2023; (doi:…
Source: nucleus.astct.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An analysis of pre-transplantation (pre-HCT) gut microbiota diversity found a correlation with improved overall survival and fewer occurrences of acute graft-versus-host disease among pediatric patients. Read more on Nucleus: https://t.co/DCYuF0gEKN #GVHD #HCT https://t.co/fvpNE04Ubb
-
-
Mashup Score: 1Embracing Autumn: A Season of Progress and Preparation - 8 month(s) ago
Here in the Northern Hemisphere, the sun is setting on summer and we are preparing ourselves for the embrace of autumn. For some, like my 13-year-old daughter, this is a celebrated change –…
Source: nucleus.astct.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Check out my @ASTCT September President Message and find out my 13 year-old daughter's favorite fall drink .... Embracing Autumn: A Season of Progress and Preparation https://t.co/j73vXDaLt9
-
-
Mashup Score: 2
What? Abstract #42: Ide-cel CAR-T therapy for relapsed/refractory multiple myeloma with renal impairment: real world experience Who? …
Source: nucleus.astct.orgCategories: Latest Headlines, Partners & KOLsTweet-
For a behind-the-scenes interview about this research with first author @SurbhiSidanaMD at #Tandem23, see our @ASTCT @Emerging_CAR_T interview here ☺️ https://t.co/G6yO8YZbCM
-
Thanks @DoctorAKrishnan for speaking with me about "Beyond BCMA" in #MMsm for @ASTCT @Emerging_CAR_T Talks! Lots of practical tips from Dr. Krishnan re: managing GPRC5D bsAbs - including some dysgeusia tips borrowed from our transplant colleagues! https://t.co/53PXNY0pFy